Citation: M. Kojima et H. Nakagami, Preparation of the controlled-release matrix tablets of theophylline with micronized low-substituted hydroxypropyl cellulose by a fluidized hot-melt granulation method, STP PHARM S, 11(2), 2001, pp. 145-150
Authors:
Taniyama, Y
Morishita, R
Aoki, M
Nakagami, H
Yamamoto, K
Yamazaki, K
Matsumoto, K
Nakamura, T
Kaneda, Y
Ogihara, T
Citation: Y. Taniyama et al., Therapeutic angiogenesis induced by human hepatocyte growth factor gene inrat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease, GENE THER, 8(3), 2001, pp. 181-189
Authors:
Yoshimura, S
Morishita, R
Hayashi, K
Yamamoto, K
Nakagami, H
Kaneda, Y
Sakai, N
Ogihara, T
Citation: S. Yoshimura et al., Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element "decoy' of nuclear factor-kB binding site as a novel molecular strategy, GENE THER, 8(21), 2001, pp. 1635-1642
Authors:
Hayashi, K
Morishita, R
Nakagami, H
Yoshimura, S
Hara, A
Matsumoto, K
Nakamura, T
Ogihara, T
Kaneda, Y
Sakai, N
Citation: K. Hayashi et al., Gene therapy for preventing neuronal death using hepatocyte growth factor:in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons, GENE THER, 8(15), 2001, pp. 1167-1173
Authors:
Aoki, M
Nata, T
Morishita, R
Matsushita, H
Nakagami, H
Yamamoto, K
Yamazaki, K
Nakabayashi, M
Ogihara, T
Kaneda, Y
Citation: M. Aoki et al., Endothelial apoptosis induced by oxidative stress through activation of NF-kappa B - Antiapoptotic effect of antioxidant agents on endothelial cells, HYPERTENSIO, 38(1), 2001, pp. 48-55
Authors:
Yamamoto, K
Morishita, R
Hayashi, S
Matsushita, H
Nakagami, H
Moriguchi, A
Matsumoto, K
Nakamura, T
Kaneda, Y
Ogihara, T
Citation: K. Yamamoto et al., Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions ofhepatocyte growth factor in hypoxia-conditioned human endothelial cells, HYPERTENSIO, 37(5), 2001, pp. 1341-1348
Authors:
Nakagami, H
Morishita, R
Yamamoto, K
Taniyama, Y
Aoki, M
Matsumoto, K
Nakamura, T
Kaneda, Y
Horiuchi, M
Ogihara, T
Citation: H. Nakagami et al., Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and Akt in endothelial cells, HYPERTENSIO, 37(2), 2001, pp. 581-586
Authors:
Sorrell, DA
Menges, M
Healy, JMS
Deveaux, Y
Amano, C
Su, Y
Nakagami, H
Shinmyo, A
Doonan, JH
Sekine, M
Murray, JAH
Citation: Da. Sorrell et al., Cell cycle regulation of cyclin-dependent kinases in tobacco cultivar bright yellow-2 cells, PLANT PHYSL, 126(3), 2001, pp. 1214-1223
Authors:
Shiuchi, T
Nakagami, H
Iwai, M
Takeda, Y
Cui, TX
Chen, R
Minokoshi, Y
Horiuchi, M
Citation: T. Shiuchi et al., Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle, ENDOCRINOL, 142(2), 2001, pp. 608-612
Authors:
Nakagami, H
Morishita, R
Yamamoto, K
Yoshimura, S
Taniyama, Y
Aoki, M
Matsubara, H
Kim, S
Kaneda, Y
Ogihara, T
Citation: H. Nakagami et al., Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells, DIABETES, 50(6), 2001, pp. 1472-1481
Authors:
Wu, L
Iwai, M
Nakagami, H
Li, Z
Chen, R
Suzuki, J
Akishita, M
de Gasparo, M
Horiuchi, M
Citation: L. Wu et al., Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury, CIRCULATION, 104(22), 2001, pp. 2716-2721
Authors:
Taniyama, Y
Morishita, R
Hiraoka, K
Aoki, M
Nakagami, H
Yamasaki, K
Matsumoto, K
Nakamura, T
Kaneda, Y
Ogihara, T
Citation: Y. Taniyama et al., Therapeutic angiogenesis induced by human hepatocyte growth factor gene inrat diabetic hind limb ischemia model - Molecular mechanisms of delayed angiogenesis in diabetes, CIRCULATION, 104(19), 2001, pp. 2344-2350
Authors:
Cui, TX
Nakagami, H
Iwai, M
Takeda, Y
Shiuchi, T
Daviet, L
Nahmias, C
Horiuchi, M
Citation: Tx. Cui et al., Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell, CARDIO RES, 49(4), 2001, pp. 863-871
Authors:
Moriguchi, A
Nakagami, H
Kotani, N
Higaki, J
Ogihara, T
Citation: A. Moriguchi et al., Contribution of cardiovascular hypersensitivity to orthostatic hypertension and the extreme dipper phenomenon, HYPERTENS R, 23(2), 2000, pp. 119-123
Authors:
Nakagami, H
Morishita, R
Yamamoto, K
Taniyama, Y
Aoki, M
Kim, S
Matsumoto, K
Nakamura, T
Higaki, J
Ogihara, T
Citation: H. Nakagami et al., Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells, J HYPERTENS, 18(10), 2000, pp. 1411-1420
Authors:
Hayashi, S
Morishita, R
Matsushita, H
Nakagami, H
Taniyama, Y
Nakamura, T
Aoki, M
Yamamoto, K
Higaki, J
Ogihara, T
Citation: S. Hayashi et al., Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21, HYPERTENSIO, 35(1), 2000, pp. 237-243
Authors:
Matsushita, H
Morishita, R
Nata, T
Aoki, M
Nakagami, H
Taniyama, Y
Yamamoto, K
Higaki, J
Yasufumi, K
Ogihara, T
Citation: H. Matsushita et al., Hypoxia-induced endothelial apoptosis through nuclear factor-kappa B (NF-kappa B)-mediated bcl-2 suppression - In vivo evidence of the importance of NF-kappa B in endothelial cell regulation, CIRCUL RES, 86(9), 2000, pp. 974-981
Authors:
Taniyama, Y
Morishita, R
Nakagami, H
Moriguchi, A
Sakonjo, H",Shokei-Kim,"Matsumoto, K
Nakamura, T
Higaki, J
Ogihara, T
Citation: Y. Taniyama et al., Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters, CIRCULATION, 102(2), 2000, pp. 246
Authors:
Yamamoto, K
Morishita, R
Tomita, N
Shimozato, T
Nakagami, H
Kikuchi, A
Aoki, M
Higaki, J
Kaneda, Y
Ogihara, T
Citation: K. Yamamoto et al., Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model - Potential application of ribozyme strategy to treat cardiovascular disease, CIRCULATION, 102(11), 2000, pp. 1308-1314
Authors:
Matsushita, H
Morishita, R
Aoki, M
Tomita, N
Taniyama, Y
Nakagami, H
Shimozato, T
Higaki, J
Kaneda, Y
Ogihara, T
Citation: H. Matsushita et al., Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells, CIRCULATION, 101(12), 2000, pp. 1447-1452
Authors:
Nakagami, H
Sekine, M
Murakami, H
Shinmyo, A
Citation: H. Nakagami et al., Tobacco retinoblastoma-related protein phosphorylated by a distinct cyclin-dependent kinase complex with Cdc2/cyclin D in vitro, PLANT J, 18(3), 1999, pp. 243-252
Authors:
Nakagami, H
Ikeda, U
Maeda, Y
Yamamoto, K
Hojo, Y
Kario, K
Kuroki, S
Shimada, K
Citation: H. Nakagami et al., Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms, J THROMB TH, 8(3), 1999, pp. 191-195